INVESTOR’S BUSINESS DAILY Gets It

This editorial from Investor’s Business Daily is right on the money. Tremeondous progress is being made in adult/umbilical cord blood stem cells (which is why it gets more private funding), all but ignored by the media in their obsession to defeat the “heartless right wing Bible thumpers.” Good for IBD for seeing through the cloning obfuscation.

Next
YOU MIGHT ALSO LIKE

Of Roots and Adventures

Peter J. Leithart

I have lived in Ohio, Michigan, Georgia (twice), Pennsylvania, Alabama (also twice), England, and Idaho. I left…

Our Most Popular Articles of 2025

The Editors

It’s been a big year for First Things. Our website was completely redesigned, and stories like the…

Our Year in Film & Television—2025

Various

First Things editors and writers share the most memorable films and TV shows they watched this year.…